Beyond Air (XAIR) Current Deferred Revenue (2019 - 2025)
Beyond Air recorded quarterly Current Deferred Revenue of $841000.0 in Q4 2025, up 477.5% quarter-over-quarter from $145628.0 in Q4 2020.
Beyond Air's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $841000.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue changed N/A year-over-year to $841000.0; the TTM figure through Dec 2025 stood at $841000.0 (changed N/A YoY), while the FY2020 annual figure was $873190.0, down 69.59% from the prior year.
- Current Deferred Revenue came in at $841000.0 for Q4 2025 at Beyond Air, up from $145628.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $841000.0 in Q4 2025 to a low of $841000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 841,000.00 |
| Dec 31, 2020 | 145,628.00 |
| Sep 30, 2020 | 294,422.00 |
| Jun 30, 2020 | 644,029.00 |
| Mar 31, 2020 | 873,190.00 |
| Dec 31, 2019 | 675,844.00 |
| Sep 30, 2019 | 990,223.00 |
| Jun 30, 2019 | 1.64 Mn |
| Mar 31, 2019 | 2.87 Mn |